Mononitrato de Isosorbida [Spanish]
Category
Mononitrato de Isosorbida [Spanish] Brand names, Mononitrato de Isosorbida [Spanish] Analogs
Mononitrato de Isosorbida [Spanish] Brand Names Mixture
Mononitrato de Isosorbida [Spanish] Chemical_Formula
C6H9NO6
Mononitrato de Isosorbida [Spanish] RX_link
http://www.rxlist.com/cgi/generic/isomono2.htm
Mononitrato de Isosorbida [Spanish] fda sheet
Mononitrato de Isosorbida [Spanish] msds (material safety sheet)
Mononitrato de Isosorbida [Spanish] Synthesis Reference
Hayward et al., Can.J.Chem., 45; 2191-2192 (1967)
Mononitrato de Isosorbida [Spanish] Molecular Weight
191.139 g/mol
Mononitrato de Isosorbida [Spanish] Melting Point
88-91oC
Mononitrato de Isosorbida [Spanish] H2O Solubility
1.07E+005 mg/L
Mononitrato de Isosorbida [Spanish] State
Solid
Mononitrato de Isosorbida [Spanish] LogP
-0.15
Mononitrato de Isosorbida [Spanish] Dosage Forms
Tablet (immediate release); Tablet (extended release)
Mononitrato de Isosorbida [Spanish] Indication
For the prevention of angina pectoris due to coronary artery disease and the treatment of acute and chronic angina pectoris, hypertension, and myocardial infarction.
Mononitrato de Isosorbida [Spanish] Pharmacology
Isosorbide-5-mononitrate, the long-acting metabolite of isosorbide dinitrate, is used as a vasodilatory agent in the management of angina pectoris. By dilating the vessels, it lowers the blood pressure and reduces the left ventricular preload and afterload, therefore, leads to a reduction of myocardial oxygen requirement.
Mononitrato de Isosorbida [Spanish] Absorption
100%
Mononitrato de Isosorbida [Spanish] side effects and Toxicity
Symptoms of overdose include vasodilatation, venous pooling, reduced cardiac output, and hypotension. LD50=mg/kg(orally in rat)
Mononitrato de Isosorbida [Spanish] Patient Information
Mononitrato de Isosorbida [Spanish] Organisms Affected
Humans and other mammals
![Mononitrato_de_Isosorbida_[Spanish]](http://pharmacycode.com/images/rx/APRD00528.gif)
